Stocksigma LogoStocksigma Logo

Shadowfax Technologies Reports Zero Deviation in IPO Proceeds Utilization for Q2FY27

CARE Ratings confirmed Shadowfax Technologies experienced zero object deviations in utilizing proceeds from its ₹1,000 crore fresh IPO issue for the

Shadowfax Technologies Reports Zero Deviation in IPO Proceeds Utilization for Q2FY27

Shadowfax Technologies Ltd · Others (Uncategorized) · 29 Oct 2026, 10:11 pm

Shadowfax Technologies Reports Zero Deviation in IPO Proceeds Utilization for Q2FY27 CARE Ratings confirmed Shadowfax Technologies experienced zero object deviations in utilizing proceeds from its ₹1,000 crore fresh IPO issue for the quarter ended 30th Sep'26. The company utilized ₹101.67 crore during Q2FY27, bringing cumulative deployment to ₹289.42 crore. Key spending included ₹76.61 crore on network infrastructure capex (reaching ₹198.18 crore cumulatively), ₹15.10 crore on facility lease rentals, and ₹7.76 crore on branding. Unutilized proceeds totaling ₹710.58 crore remain predominantly invested in bank fixed deposits earning 6.50%–7.25% yields.

Original exchange filing (PDF)

More announcements from Shadowfax Technologies Ltd

All Shadowfax Technologies Ltd announcements